NEWS

Surge in Data Integrity Findings in GxP Inspections

Recent inspection trends reinforce a fundamental principle: organisations cannot control risks that they cannot see. Data integrity failures, supply chain vulnerabilities, and system fragmentation all... ...more

News

April 15, 20266 min read

Surge in Data Integrity Findings in GxP Inspections

We specialise in training for start ups

Start up organisations in regulated life science industries operate in complex and rapidly evolving environments where scientific innovation must be balanced with regulatory compliance. Structured tra... ...more

News

April 01, 20265 min read

We specialise in training for start ups

TGA Compliance Principles 2026–2027: A Proactive and Risk-Based Approach

The TGA Compliance Principles for 2026 and 2027 reflect a proactive, risk-based approach to safeguarding public health through the regulation of therapeutic goods. ...more

News

February 03, 20265 min read

TGA Compliance Principles 2026–2027: A Proactive and Risk-Based Approach

Funding & Investor Expectations

For therapeutic goods, biotechnology, and medical device startups, securing funding is not simply a matter of demonstrating innovative science. Investors require evidence of robust governance, clear r... ...more

News

January 20, 20264 min read

Funding & Investor Expectations

Explore Complimentary Training Courses at QSN Academy

For therapeutic goods manufacturers, testing laboratories, and biotechnology companies, engaging with QSN Academy’s complimentary courses represents a strategic investment in personnel development, op... ...more

Quality Training ,News

January 03, 20265 min read

Explore Complimentary Training Courses at QSN Academy

Happy New Year 2026: Advancing Quality and Compliance in the MedTech and Pharmaceutical Industries

Entering 2026 with a commitment to quality, compliance, and professional development positions MedTech and pharmaceutical organizations for continued growth, regulatory success, and positive impact on... ...more

News

December 31, 20255 min read

Happy New Year 2026: Advancing Quality and Compliance in the MedTech and Pharmaceutical Industries
Back to Home